Altered conductance and permeability of Cx40 mutations associated with atrial fibrillation

Ana Santa Cruz1, Gülistan Meşe1, Laima Valiuniene1

  • 1Department of Physiology and Biophysics, Stony Brook University, Stony Brook, NY 11792.

Insights

Mutant connexin40 (Cx40) proteins associated with atrial fibrillation alter gap junction channel properties. These biophysical changes in Cx40 mutants may contribute to cardiac arrhythmias like reentry.

Area of Science:

  • Cardiovascular Biology
  • Molecular Biophysics
  • Genetics

Background:

  • Gap junctions, formed by connexin proteins, are crucial for rapid electrical impulse propagation in the heart.
  • Mutations in connexin40 (Cx40), the main component of atrial gap junctions, are linked to atrial fibrillation.
  • The specific biophysical alterations of Cx40 mutants contributing to arrhythmias are not fully understood.

Purpose of the Study:

  • To investigate the biophysical properties of three Cx40 mutants (A96S, M163V, G38D) associated with atrial fibrillation.
  • To compare the unitary conductance, ion permeability, and dye permeability of mutant Cx40 channels to wild-type (WT) Cx40.
  • To elucidate how these altered channel properties may contribute to cardiac arrhythmias.

Main Methods:

  • Transiently transfected HeLa and N2A cells were used to express WT Cx40 and its mutants.
  • Macroscopic and unitary conductances were measured.
  • Permeability assays using Lucifer yellow (anionic dye) and ethidium bromide (cationic dye) relative to K+ were performed.

Main Results:

  • All Cx40 mutants formed functional channels with comparable macroscopic conductances and voltage dependences to WT Cx40.
  • The G38D mutant exhibited significantly higher unitary conductance and increased Lucifer yellow permeability compared to WT Cx40.
  • The M163V and G38D mutants showed altered ion selectivity, with increased ethidium bromide permeability, while G38D showed reduced permeability, suggesting changes in channel pore characteristics.

Conclusions:

  • Mutations in Cx40 associated with atrial fibrillation alter both conductive and permeability properties of gap junction channels.
  • These biophysical changes in Cx40 mutants may underlie the mechanisms of reentry arrhythmias.
  • Cx40-mediated electrical and biochemical coupling is essential for normal cardiac function, and its disruption by mutations can lead to disease.

Related Concept Videos

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
2.9K
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
957
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
2.6K
G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
6.9K
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
109
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
2.6K